...
首页> 外文期刊>ANZ journal of surgery >Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology
【24h】

Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology

机译:乳腺癌术中前哨淋巴结评估:基于CK19 mRNA表达和印迹细胞学的快速诊断方法的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Sentinel lymph node biopsy in breast cancer is a routine technique for staging the axilla. The two most common methods of intraoperative histopathological assessment, imprint cytology and frozen section, are hampered by poor sensitivity and lack standardized methodology. The one-step nuclei acid amplification (OSNA) assay is a rapid quantification of cytokeratin 19 mRNA. This prospective study compared an existing intraoperative imprint cytology protocol with the OSNA system. Methods: Of the 110 prospectively recruited patients, 98 met the inclusion criteria with a total of 170 lymph nodes. Intraoperative sentinel nodes were serially sectioned and imprints made of each cut surface for cytological assessment. Alternate slices were submitted for OSNA while the remaining slices were for final histopathological evaluation with six hematoxylin and eosin levels and one AE1/AE3 immuno-peroxidase stain of each slice.Results: On histopathological analysis, 24.5% of patients (16.5% of nodes) had sentinel node metastases and 3.1% (2.4%) had isolated tumour cells. With isolated tumour cells cases taken as negative, the sensitivity of imprint cytology and OSNA compared with histopathology were 66.7% on patient basis (71.4% on per-node basis) and 95.8% (89.3%), respectively. One of 22 patients with macrometastases and two of three micrometastases were designated negative while five false-positive nodes were identified with OSNA, likely due to tissue allocation bias.Conclusion: The OSNA assay is highly sensitive in comparison with imprint cytology and may be used effectively in the intraoperative setting. Clinical follow-up studies are warranted to further assess its use in routine practice.
机译:背景:乳腺癌前哨淋巴结活检是腋窝分期的常规技术。术中组织病理学评估的两种最常见方法,即印记细胞学和冰冻切片,由于敏感性差和缺乏标准化方法而受到阻碍。一步核酸扩增(OSNA)分析是对细胞角蛋白19 mRNA的快速定量。这项前瞻性研究将现有的术中烙印细胞学方案与OSNA系统进行了比较。方法:在110名预期入组患者中,有98名符合入选标准,共170个淋巴结。术中对前哨淋巴结进行连续切片,并在每个切面上留下印记以进行细胞学评估。备用切片送至OSNA,其余切片用于最终的组织病理学评估,每片含6个苏木和曙红水平和1个AE1 / AE3免疫过氧化物酶染色。有前哨淋巴结转移,有3.1%(2.4%)有分离的肿瘤细胞。以孤立的肿瘤细胞为阴性,与患者相比,印迹细胞学和OSNA与组织病理学的敏感性分别为66.7%(按每个结点为71.4%)和95.8%(89.3%)。结论:OSNA检测与印迹细胞学检查相比具有较高的敏感性,可将22例巨转移灶中的1例确定为阴性,将3例微转移中的2例确定为OSNA阴性,而将5个假阳性淋巴结鉴别为OSNA。在术中有必要进行临床随访研究以进一步评估其在常规实践中的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号